{"Title": "Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution", "Year": 2018, "Source": "Ann. Oncol.", "Volume": "29", "Issue": 3, "Art.No": null, "PageStart": 563, "PageEnd": 572, "CitedBy": 41, "DOI": "10.1093/annonc/mdy003", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046094021&origin=inward", "Abstract": "\u00a9 The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.The apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) mutational signature has only recently been detected in a multitude of cancers through next-generation sequencing. In contrast, APOBEC has been a focus of virology research for over a decade. Many lessons learnt regarding APOBEC within virology are likely to be applicable to cancer. In this review, we explore the parallels between the role of APOBEC enzymes in HIV and cancer evolution. We discuss data supporting the role of APOBEC mutagenesis in creating HIV genome heterogeneity, drug resistance, and immune escape variants. We hypothesize similar functions of APOBEC will also hold true in cancer.", "AuthorKeywords": ["APOBEC", "Drug resistance", "Human immunodeficiency virus", "Immune escape", "Intratumour heterogeneity"], "IndexKeywords": ["Animals", "APOBEC Deaminases", "Drug Resistance", "HIV", "HIV Infections", "Humans", "Immune Tolerance", "Mutagenesis", "Neoplasms"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85046094021", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"]], "AuthorData": {"56453995200": {"Name": "Venkatesan S.", "AuthorID": "56453995200", "AffiliationID": "60107285", "AffiliationName": "Translational Cancer Therapeutics Laboratory, The Francis Crick Institute"}, "57150146000": {"Name": "Rosenthal R.", "AuthorID": "57150146000", "AffiliationID": "60109234, 60172353", "AffiliationName": "CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute"}, "6506799928": {"Name": "Kanu N.", "AuthorID": "6506799928", "AffiliationID": "60109234, 60172353", "AffiliationName": "CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute"}, "54956605300": {"Name": "McGranahan N.", "AuthorID": "54956605300", "AffiliationID": "60109234, 60172353", "AffiliationName": "CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute"}, "12762916100": {"Name": "Quezada S.A.", "AuthorID": "12762916100", "AffiliationID": "60109234", "AffiliationName": "Cancer Immunology Unit, UCL Cancer Institute"}, "7005912775": {"Name": "Swanton C.", "AuthorID": "7005912775", "AffiliationID": "60107285", "AffiliationName": "Translational Cancer Therapeutics Laboratory, The Francis Crick Institute"}, "7103077558": {"Name": "Bartek J.", "AuthorID": "7103077558", "AffiliationID": "60012311", "AffiliationName": "Division of Genome Biology, Department of Biochemistry and Biophysics, Karolinska Institute"}, "57201773411": {"Name": "Hare J.", "AuthorID": "57201773411", "AffiliationID": "60090013", "AffiliationName": "International AIDS Vaccine Initiative (IAVI)"}, "7405694787": {"Name": "Harris R.S.", "AuthorID": "7405694787", "AffiliationID": "60029445, 60009470", "AffiliationName": "Howard Hughes Medical Institute, University of Minnesota"}}}